DFFVX | FCVAX | DFFVX / FCVAX | |
Total Expense Ratio | 0.29 | 1.26 | 23% |
Annual Report Gross Expense Ratio | 0.30 | 1.26 | 24% |
Fund Existence | 26 years | 21 years | - |
Gain YTD | 6.684 | -0.495 | -1,349% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.6B | 4.58B | 297% |
Annual Yield % from dividends | 1.68 | 0.61 | 273% |
Returns for 1 year | 9.59 | -1.20 | -801% |
Returns for 3 years | 43.52 | 22.83 | 191% |
Returns for 5 years | 96.30 | 48.70 | 198% |
Returns for 10 years | 77.54 | 16.44 | 472% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CIVGX | 20.49 | 0.11 | +0.54% |
American Funds International Vntg 529-F2 | |||
IJSTX | 13.83 | N/A | N/A |
VY® JPMorgan Small Cap Core Equity S2 | |||
MRLOX | 18.85 | N/A | N/A |
BlackRock Global Allocation R | |||
SWLVX | 16.05 | N/A | N/A |
Schwab ® US Large-Cap Value Index | |||
LQFLX | 15.16 | N/A | N/A |
Lord Abbett Focused Large Cap Value R3 |